Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018198 · ClinicalTrials.gov registry record
FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test
A clinical trial, sponsored by Rapid Pathogen Screening.
- Completed
- Registry status
- 540
- Enrollment target
NCT02018198 is a clinical trial that has completed, run by Rapid Pathogen Screening. The registered enrollment target is 540 participants.
The verdict
NCT02018198 has completed, sponsored by Rapid Pathogen Screening.
- COMPLETED
- Registry status
- 540 participants
- Enrollment target
Study Summary
The aim of this study is to determine performance characteristics of the FebriDx test in predicting viral or bacterial infection etiology among febrile (observed or reported) patients presenting the emergency department, urgent care centers or primary care offices with suspected acute respiratory tract infection.
Interventions
- DIAGNOSTIC_TEST FebriDx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2021-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02018198
The ClinicalTrials.gov registry entry for NCT02018198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rapid Pathogen Screening, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FebriDx is the first listed.
NCT02018198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02018198 about?
NCT02018198 is a clinical study titled "FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test". The aim of this study is to determine performance characteristics of the FebriDx test in predicting viral or bacterial infection etiology among febrile (observed or reported) patients presenting the emergency department, urgent care centers or primary care offices with suspected acute respiratory tr...
What is the current status of trial NCT02018198?
This trial is currently completed. The enrollment target is 540 participants. The study started on 2019-10-15. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT02018198?
The interventions under investigation include: FebriDx (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02018198?
This trial is sponsored by Rapid Pathogen Screening, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.